Editas Medicine, Inc.
$2.65
The Read: 3% on strong Q4 2025 results and mid-2026 IND/CTA timing confirmation, but falling 16.
Price
Overlays
Panel
EDIT
Hover to view data
No Data
By creating an account you agree to our Terms of Service and Privacy Policy.
$2.65
The Read: 3% on strong Q4 2025 results and mid-2026 IND/CTA timing confirmation, but falling 16.
No Data